55 related articles for article (PubMed ID: 3062907)
1. [Liver function parameters and fibrinogen in intra-arterial and intravenous PGE1 infusion].
Sinzinger H; Fitscha P
Wien Klin Wochenschr; 1988 Jul; 100(14):488-90. PubMed ID: 3062907
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
[TBL] [Abstract][Full Text] [Related]
3. [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders].
Heidrich H
Vasa Suppl; 1991; 33():346-7. PubMed ID: 1788752
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of hepatic arterial infusion of prostaglandin E1 in the treatment of postoperative acute liver failure--report of a case.
Sato T; Asanuma Y; Hashimoto M; Heianna J; Kusano T; Kurokawa T; Yasui O; Koyama K
Hepatogastroenterology; 2000; 47(33):846-50. PubMed ID: 10919045
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
Balzer K; Rogatti W; Rüttgerodt K
Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion.
Kato T; Sato T; Kurokawa T; Nanjo H; Asanuma Y; Koyama K
Transplantation; 2003 Nov; 76(9):1340-5. PubMed ID: 14627913
[TBL] [Abstract][Full Text] [Related]
7. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
Lynch TG; Hobson RW; Barbalinardo JP; Kerr JC
Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
[TBL] [Abstract][Full Text] [Related]
8. [The effect of low-dose prostaglandin E1 on intra- and post-operative liver function].
Hayashida M; Hanaoka K; Shimada Y; Namiki A; Amaha K
Masui; 1997 May; 46(5):618-27. PubMed ID: 9185458
[TBL] [Abstract][Full Text] [Related]
9. [Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Takeda S; Ikeba K; Ohokubo T; Sodemoto T; Yamamoto T; Takagi A; Hayashi N; Kinoshita K
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1697-703. PubMed ID: 8886048
[TBL] [Abstract][Full Text] [Related]
10. [Intravenous PGE-1 in peripheral vascular obstructive disease: use over a 6-month period].
Llorente Gutiérrez J; González Fernández MA; Fuentes Irigoyen R; Jiménez Caballero E
Farm Hosp; 2004; 28(3):188-91. PubMed ID: 15222872
[TBL] [Abstract][Full Text] [Related]
11. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.
Caspary L; Creutzig A; Radeke U; Specht S; Alexander K
Biomed Biochim Acta; 1988; 47(10-11):S307-10. PubMed ID: 3073766
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster.
Kanai A; Osawa S; Suzuki A; Ishimaru R; Hoka S
Pain Med; 2007; 8(1):36-40. PubMed ID: 17244102
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer].
Uchida J; Okada H; Ohguchi N; Kawa G; Koyama Y; Mikami O; Kawamura H; Ohhara T; Matsuda T
Hinyokika Kiyo; 1997 Sep; 43(9):637-40. PubMed ID: 9365842
[TBL] [Abstract][Full Text] [Related]
14. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
[TBL] [Abstract][Full Text] [Related]
15. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
16. Midterm results of prostaglandin E1 treatment in patients with lumbar spinal canal stenosis accompanied by intermittent claudication.
Nakanishi K; Tanaka M; Misawa H; Takigawa T; Ozaki T
Spine (Phila Pa 1976); 2008 Jun; 33(13):1465-9. PubMed ID: 18520942
[TBL] [Abstract][Full Text] [Related]
17. [Effect of PGE1 on the left ventricular ejection fraction].
Auinger C; Weissel M; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1988 Nov; 100(21):706-9. PubMed ID: 3242306
[TBL] [Abstract][Full Text] [Related]
18. [Intravenous infusion of prostagrandin E1 during and after gastrectomy on postoperative hepato-renal functions in senile patients].
Murakawa T; Shimodate Y; Matsuki A; Tanaka T; Takeuchi M; Ino M; Tateoka H; Yokoyama M; Ohishi S
Masui; 1996 Mar; 45(3):356-61. PubMed ID: 8721140
[TBL] [Abstract][Full Text] [Related]
19. Improvement of microcirculation after percutaneous transluminal angioplasty in the lower limb with prostaglandin E1.
Heider P; Wildgruber M; Wolf O; Schuster T; Lutzenberger W; Berger H; Eckstein HH
Prostaglandins Other Lipid Mediat; 2009 Jan; 88(1-2):23-30. PubMed ID: 18832042
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma.
Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T
Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
